Amrize AG · AMRZ · FY2026 Q3 · Calendar Q4 2026
Amrize: Pricing and M&A offset volume and cost pressures
Amrize’s current analysis supports a constructive but qualified view: pricing, acquisitions, infrastructure-linked demand and savings initiatives are supporting growth, while volume softness, Building Envelope pressure and input-cost inflation remain important offsets.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about AMRZ FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, the current analysis shows slower reported revenue growth but continued pricing support, a completed $1 billion repurchase, higher year-to-date ASPIRE savings, and a stronger emphasis on reducing cement imports.
Guidance delta
Management’s guidance sentiment remained raised; the supplied Q3 analysis says 2026 revenue guidance was lifted to $12.2-$12.4 billion and EBITDA guidance to $2.95-$3.05 billion.
Key takeaways
- Q3 growth was led by pricing, surcharges and acquisitions, while residential roofing remained soft.
- Building Materials margins expanded, but Building Envelope faced cost inflation and demand pressure.
- Management highlighted continued capacity investment, ASPIRE savings and additional acquisitions.
Management priorities
- Expand cement production and debottleneck terminals and quarries.
- Launch the Malarkey shingle plant in Indiana and pursue aligned bolt-on acquisitions.
- Advance ASPIRE savings and increase reliance on domestic cement production.
Follow AMRZ with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 19, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 13, 2026 |
| RBC Capital | Underperform | Underperform | Maintain | Oct 9, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 5, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 2, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 23, 2026 |
| UBS | Neutral | Neutral | Maintain | Sep 22, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Sep 18, 2026 |
| B of A Securities | Underperform | Neutral | Downgrade | Sep 2, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Aug 12, 2026 |
Named analyst price targets
Upside is calculated against the persisted current price $41.61. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Adam Seiden | $40 | $37.82 | -3.9% | Oct 19, 2026 |
| D.A. Davidson | Garik Shmois | $40 | $36.38 | -3.9% | Oct 9, 2026 |
| RBC Capital | Anthony Codling | $32 | $36.5 | -23.1% | Oct 9, 2026 |
| Truist Financial | Analyst unavailable | $35 | $37.26 | -15.9% | Oct 5, 2026 |
| Wells Fargo | Analyst unavailable | $40 | $37.26 | -3.9% | Oct 5, 2026 |
| Barclays | Adam Seiden | $55 | $37.39 | +32.2% | Oct 1, 2026 |
| Deutsche Bank | Jon Bell | $56 | $38.14 | +34.6% | Sep 23, 2026 |
| UBS | Analyst unavailable | $42 | $39.19 | +0.9% | Sep 22, 2026 |
| Bernstein | Pujarini Ghosh | $60 | $37.54 | +44.2% | Sep 21, 2026 |
| Oppenheimer | Analyst unavailable | $55 | $37.44 | +32.2% | Sep 18, 2026 |
| Wells Fargo | Analyst unavailable | $44 | $41.95 | +5.7% | Sep 9, 2026 |
| William Blair | Analyst unavailable | $40 | $42.81 | -3.9% | Sep 2, 2026 |
| D.A. Davidson | Analyst unavailable | $50 | $45.18 | +20.2% | Aug 24, 2026 |
| Stephens | Analyst unavailable | $54 | $46.9 | +29.8% | Aug 12, 2026 |
| RBC Capital | Anthony Codling | $48 | $46.64 | +15.4% | Aug 10, 2026 |
| Wells Fargo | Analyst unavailable | $58 | $50.94 | +39.4% | Jul 8, 2026 |
| Truist Financial | Keith Hughes | $48 | $54.01 | +15.4% | Jul 7, 2026 |
| Morgan Stanley | Analyst unavailable | $63 | $53.42 | +51.4% | Jun 22, 2026 |
| Morgan Stanley | Analyst unavailable | $65 | $54.48 | +56.2% | May 6, 2026 |
| Oppenheimer | Analyst unavailable | $68 | $53.38 | +63.4% | May 1, 2026 |
| Vertical Research | Analyst unavailable | $70 | $53.78 | +68.2% | May 1, 2026 |
| Wells Fargo | Timna Tanners | $65 | $59.96 | +56.2% | Apr 15, 2026 |
| Truist Financial | Analyst unavailable | $75 | $65 | +80.2% | Feb 20, 2026 |
| Oppenheimer | Analyst unavailable | $70 | $63.7 | +68.2% | Feb 19, 2026 |
| Wells Fargo | Timna Tanners | $66 | $63.7 | +58.6% | Feb 19, 2026 |
| Berenberg Bank | Analyst unavailable | $70 | $63.7 | +68.2% | Feb 19, 2026 |
| Wells Fargo | Analyst unavailable | $59 | $53.64 | +41.8% | Jan 29, 2026 |
| Oppenheimer | Analyst unavailable | $64 | $54.6 | +53.8% | Jan 15, 2026 |
| Goldman Sachs | Analyst unavailable | $58 | $57.32 | +39.4% | Jan 12, 2026 |
| Bernstein | Pujarini Ghosh | $70 | $53.54 | +68.2% | Dec 18, 2025 |
| RBC Capital | Anthony Codling | $60 | $54.74 | +44.2% | Dec 8, 2025 |
| Deutsche Bank | Analyst unavailable | $59 | $54.74 | +41.8% | Dec 8, 2025 |
| Vertical Research | Michael Dudas | $54 | $50.13 | +29.8% | Nov 25, 2025 |
| Morgan Stanley | Analyst unavailable | $61 | $52.85 | +46.6% | Oct 29, 2025 |
| UBS | Analyst unavailable | $52 | $48.21 | +25.0% | Oct 14, 2025 |
| Wells Fargo | Timna Tanners | $57 | $47.13 | +37.0% | Oct 7, 2025 |
| RBC Capital | Anthony Codling | $54 | $47.02 | +29.8% | Aug 8, 2025 |
| Berenberg Bank | Analyst unavailable | $64 | $49.55 | +53.8% | Jun 30, 2025 |
| Jefferies | Analyst unavailable | $52.5 | $49.01 | +26.2% | Jun 29, 2025 |
| Truist Financial | Analyst unavailable | $60 | $53 | +44.2% | Jun 24, 2025 |
Track every rating change on AMRZ the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAmrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.
Historical context
All AMRZ earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AGI Alamos Gold Inc. | FY2026 Q3 · Calendar Q4 2026 | 0.0% | -9.0% | Alamos Gold Reports Record Island Gold Output as Shaft Timing Slips |
| VMC Vulcan Materials Company | FY2026 Q3 · Calendar Q4 2026 | — | +5.8% | Vulcan pairs 5% EBITDA growth with acquisitions and pricing |
| AEM Agnico Eagle Mines Limited | FY2026 Q3 · Calendar Q4 2026 | +5.7% | -3.9% | Agnico Eagle Maintains Guidance as Growth Investment Accelerates |
| LIN Linde plc | FY2026 Q3 · Calendar Q4 2026 | — | -1.4% | Linde keeps FY guidance as restructuring weighs on near-term outlook |
| KGC Kinross Gold Corporation | FY2026 Q3 · Calendar Q4 2026 | +8.7% | -6.1% | Kinross maintains 2026 outlook as cash flow and projects advance |
Latest beats and misses
Who reports nextBeat on EPS
- TYLFY2026 Q3 · October 28, 2026+1.1% EPS+3.6% move
- EHCFY2026 Q3 · October 28, 2026+11.8% EPS+7.7% move
- AGIFY2026 Q3 · October 28, 20260.0% EPS-9.0% move
- ARFY2026 Q3 · October 28, 2026+22.3% EPS-2.2% move
- INVHFY2026 Q3 · October 28, 2026+49.5% EPS-0.4% move
- AEMFY2026 Q3 · October 28, 2026+5.7% EPS-3.9% move
Get the AMRZ recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-29T18:08:03.172563+00:00
- FN2 earnings calendar · 2026-10-29T01:23:20.584741+00:00
- Polygon adjusted daily market bars · 2026-10-30T01:00:42.536793+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T01:00:42.534152+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.